Cognitive effects of methylphenidate and levodopa in healthy volunteers

European Neuropsychopharmacology

Volumn 24, Issue 2, 2014, Pages 200-206

  Linssen, A M W ^a   Sambeth, A ^a   Vuurman, E F P M ^a   Riedel, W J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Dopamine; Event related potentials; Levodopa; Memory; Methylphenidate

Indexed keywords

DOMPERIDONE; LEVODOPA; METHYLPHENIDATE; PLACEBO;

ADULT; ARTICLE; COGNITION; CROSSOVER PROCEDURE; DECLARATIVE MEMORY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EVENT RELATED POTENTIAL; FEMALE; HUMAN; HUMAN EXPERIMENT; LEARNING; LEARNING TEST; MALE; NORMAL HUMAN; PAIRED ASSOCIATES LEARNING TASK; PRIORITY JOURNAL; RECALL; RESPONSE TIME; TASK PERFORMANCE; WORKING MEMORY; YOUNG ADULT;

DOPAMINE; EVENT-RELATED POTENTIALS; LEVODOPA; MEMORY; METHYLPHENIDATE;

ADOLESCENT; ADULT; ASSOCIATION LEARNING; BRAIN; CROSS-OVER STUDIES; DOPAMINE AGENTS; DOPAMINE UPTAKE INHIBITORS; DOUBLE-BLIND METHOD; EVOKED POTENTIALS; FEMALE; HEALTHY VOLUNTEERS; HUMANS; LEVODOPA; MALE; MEMORY; MEMORY, SHORT-TERM; MENTAL RECALL; METHYLPHENIDATE; RECOGNITION (PSYCHOLOGY); SPACE PERCEPTION; YOUNG ADULT;

EID: 84893684696     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2013.09.009     Document Type: Article

References (47)

1. Agay N., Yechiam E., Carmel Z., Levkovitz Y. Non-specific effects of methylphenidate (Ritalin) on cognitive ability and decision-making of ADHD and healthy adults. Psychopharmacology (Berlin) 2010, 210:511-519.
2. Bishop C., Roehrs T., Rosenthal L., Roth T. Alerting effects of methylphenidate under basal and sleep-deprived conditions. Experimental and Clinical Psychopharmacology 1997, 5:344-352.
3. Bond A., Lader M. The use of analog scales in rating subjective feelings. British Journal of Medical Psychology 1974, 47:211-218.
4. Breitenstein C., Floel A., Korsukewitz C., Wailke S., Bushuven S., Knecht S. A shift of paradigm: from noradrenergic to dopaminergic modulation of learningα. Journal of the Neurological Sciences 2006, 248:42-47.
5. Chamberlain S.R., Muller U., Blackwell A.D., Robbins T.W., Sahakian B.J. Noradrenergic modulation of working memory and emotional memory in humans. Psychopharmacology 2006, 188:397-407.
6. Chan S.C., Chan C.C., Kwan A.S., Ting K.H., Chui T.Y. Orienting attention modulates pain perception: an ERP study. PLoS ONE 2012, 7:e40215.
7. Coull J.T. Neural correlates of attention and arousal: insights from electrophysiology, functional neuroimaging and psychopharmacology. Progress in Neurobiology 1998, 55:343-361.
8. Coull J.T., Frith C.D., Dolan R.J., Frackowiak R.S., Grasby P.M. The neural correlates of the noradrenergic modulation of human attention, arousal and learning. European Journal of Neuroscience 1997, 9:589-598.
9. Elliott R., Sahakian B.J., Matthews K., Bannerjea A., Rimmer J., Robbins T.W. Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology (Berlin) 1997, 131:196-206.
10. Friedman D., Johnson R. Event-related potential (ERP) studies of memory encoding and retrieval: a selective review. Microscopy Research and Technique 2000, 51:6-28.
11. Hannestad J., Gallezot J.D., Planeta-Wilson B., Lin S.F., Williams W.A., van Dyck C.H., et al. Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo. Biological Psychiatry 2010, 68:854-860.
12. Jasper H.H. The ten-twenty electrode system of the International Federation. Electroencephalography and Clinical Neurophysiology 1958, 10:370-375.
13. Kessels R.P., Postma A., de Haan E.H. Object relocation: a program for setting up, running, and analyzing experiments on memory for object locations. Behavior Research Methods, Instruments, & Computers 1999, 31:423-428.
14. Kessels R.P., Postma A., Wester A.J., de Haan E.H. Memory for object locations in Korsakoff's amnesia. Cortex 2000, 36:47-57.
15. Klaassen T., Riedel W.J., Deutz N.E., Van Praag H.M. Mood congruent memory bias induced by tryptophan depletion. Psychological Medicine 2002, 32:167-172.
16. Knecht S., Breitenstein C., Bushuven S., Wailke S., Kamping S., Floel A., et al. Levodopa: faster and better word learning in normal humans. Annals of Neurology 2004, 56:20-26.
17. Kollins S.H., Rush C.R., Pazzaglia P.J., Ali J.A. Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate. Experimental and Clinical Psychopharmacology 1998, 6:367-374.
18. Kuczenski R., Segal D.S. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. Journal of Neurochemistry 1997, 68:2032-2037.
19. Lefebvre C.D., Marchand Y., Eskes G.A., Connolly J.F. Assessment of working memory abilities using an event-related brain potential (ERP)-compatible digit span backward task. Clinical Neurophysiology 2005, 116:1665-1680.
20. Levy F. Dopamine vs noradrenaline: inverted-U effects and ADHD theories. Australian & New Zealand Journal of Psychiatry 2009, 43:101-108.
21. Lezak M.D. Neuropsychological Assessment 1995, Oxford University Press, New York. 3rd ed.
22. Linssen A.M., Riedel W.J., Sambeth A. Effects of tyrosine/phenylalanine depletion on electrophysiological correlates of memory in healthy volunteers. Journal of Psychopharmacology 2011, 25:230-238.
23. Linssen A.M., Vuurman E.F., Sambeth A., Nave S., Spooren W., Vargas G., et al. Contingent negative variation as a dopaminergic biomarker: evidence from dose-related effects of methylphenidate. Psychopharmacology (Berlin) 2011, 218:533-542.
24. Linssen A.M., Vuurman E.F., Sambeth A., Riedel W.J. Methylphenidate produces selective enhancement of declarative memory consolidation in healthy volunteers. Psychopharmacology 2012, 221:611-619.
25. McNair D., Lorr M., Droppleman L. EdITS Manual for the Profile of Mood States 1992, Educational and Industrial Testing Service, San Diego.
26. Mecklinger A. The control of long-term memory: brain systems and cognitive processes. Neuroscience and Biobehavioral Reviews 2010, 34:1055-1065.
27. Mehta M.A., Owen A.M., Sahakian B.J., Mavaddat N., Pickard J.D., Robbins T.W. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. Journal of Neuroscience 2000, 20:RC65.
28. Nieoullon A. Dopamine and the regulation of cognition and attention. Progress in Neurobiology 2002, 67:53-83.
29. Otten L.J., Donchin E. Relationship between P300 amplitude and subsequent recall for distinctive events: dependence on type of distinctiveness attribute. Psychophysiology 2000, 37:644-661.
30. Owen A.M., Hampshire A., Grahn J.A., Stenton R., Dajani S., Burns A.S., et al. Putting brain training to the test. Nature 2010, 465:775-778.
31. Pacholczyk T., Blakely R.D., Amara S.G. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 1991, 350:350-354.
32. Pietrzak R.H., Mollica C.M., Maruff P., Snyder P.J. Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder. Neuroscience & Biobehavioral Reviews 2006, 30:1225-1245.
33. Polich J. Updating P300: an integrative theory of P3a and P3b. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology 2007, 118:2128-2148.
34. Polich J. Neuropsychology of P300. The Oxford Handbook of Event-Related Potential Components 2012, Oxford University Press, Oxford. S.J. Luck, E.S. Kappenman (Eds.).
35. Polich J., Criado J.R. Neuropsychology and neuropharmacology of P3a and P3b. International Journal of Psychophysiology: Official Journal of the International Organization of Psychophysiology 2006, 60:172-185.
36. Repantis D., Schlattmann P., Laisney O., Heuser I. Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacological Research: The Official Journal of the Italian Pharmacological Society 2010, 62:187-206.
37. Sambeth A., Blokland A., Harmer C.J., Kilkens T.O., Nathan P.J., Porter R.J., et al. Sex differences in the effect of acute tryptophan depletion on declarative episodic memory: a pooled analysis of nine studies. Neuroscience and Biobehavioral Reviews 2007, 31:516-529.
38. Schellekens A.F., van Oosterwijck A.W., Ellenbroek B., de Jong C.A., Buitelaar J.K., Cools L., et al. The dopamine agonist apomorphine differentially affects cognitive performance in alcohol dependent patients and healthy controls. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 2009, 19:68-73.
39. Seeman P., Madras B. Methylphenidate elevates resting dopamine which lowers the impulse-triggered release of dopamine: a hypothesis. Behavioral Brain Research 2002, 130:79-83.
40. Smith M.E., Farah M.J. Are prescription stimulants "smart pills"α The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychological Bulletin 2011, 137:717-741.
41. Sternberg S. High-speed scanning in human memory. Science 1966, 153:652-654.
42. Swaab T.Y., Ledoux K., Camblin C.C., Boudewyn M.A. Language-related ERP components. The Oxford Handbook of Event-Related Potential Components 2012, Oxford University Press, Oxford. S.J. Luck, E.S. Kappenman (Eds.).
43. van Ruitenbeek P., Vermeeren A., Riedel W. Histamine H1-receptor blockade in humans affects psychomotor performance but not memory. [Research Support, Non-U.S. Gov't]. Journal of Psychopharmacology 2008, 22:663-672.
44. Volkow N.D., Wang G.J., Fowler J.S., Gatley S.J., Logan J., Ding Y.S., et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. American Journal of Psychiatry 1998, 155:1325-1331.
45. Winer J. Statistical principles in experimental design 1971, McGraw-Hill, New York.
46. World Medical Association Declaration of Helsinki, 2008.
47. Zeeuws I., Soetens E. Verbal memory performance improved via an acute administration of d-amphetamine. Human Psychopharmacology 2007, 22:279-287.